College’s too-fat-to-graduate rule under fire
Most college students expect to receive their diplomas on the basis of grades, but at a Pennsylvania school, physical fitness matters too.
You are currently browsing the archives for November, 2009
Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma … (PR Newswire via Yahoo! Finance)
Reportlinker.com announces that a new market research report is available in its catalogue:
Plasma PLTP activity is inversely associated with HDL-C levels
Phospholipid transfer protein (PLTP) is an important modulator of lipoprotein metabolism, including interparticle phospholipid transfer, remodeling of HDL, cholesterol and phospholipid efflux from peripheral tissues, and the production of hepatic VLDL. PLTP also plays an important role in inflammation and oxidative stress. Accordingly, PLTP has been implicated in the development of atherosclerosis. In this study, we evaluated the association between PLTP activity and lipoprotein metabolism in a Chinese patients cohort with or without coronary heart disease(CHD group n=407, control group n=215), the PLTP activity was measured and PLTP genotyping was screened for sequence anomalies by PCR. We found that human plasma PLTP activity was negatively associated with plasma HDL and apoA-I levels, and positively associated with plasma TG, apoB and apoE levels. We also found that PLTP rs2294213 polymorphism was tended to be associated with increased plasma PLTP activity.
Area elementary schools bite on public board’s draft nutrition policy (Ancaster News)
Hamilton-Wentworth District School Board’s draft nutrition policy for public consultation to strengthen nutritional practices in schools and eliminate foods with minimal nutritional value is getting a positive response from area elementary school officials.
Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence
Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) announced today that the Harvard Medical School ICCB-Longwood Screening Facility (ICCB-L) has been recognized as a MicroRNA Screening Center of Excellence. ICCB-L supports investigators at Harvard Medical School, and associated hospitals and institutions, for high-throughput screening of small molecule and RNAi libraries. (PRWeb Nov 30, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3262884.htm
DuPont Sponsors Premiere Science Competition for 24th Year
Company Calls for Entries to DuPont Challenge© 2010 Science Essay Competition to Increase Science Literacy (PRWeb Nov 30, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3275654.htm
Pajama Pathology — the New Wave of Preclinical Pathology Embraced by PDS
PDS, a leader in providing smart and efficient software to the preclinical community, announces Pajama Pathology®, evolutionizing work-from-home histopathology by utilizing the same ‘gold standard’ software used by 8 of the Top 10 Pharmaceutical Companies in the world, but on a ‘cost per slide’ basis. (PRWeb Nov 30, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3199514.htm
ShowMyPC Provides First Online Service in the World to Access Personal Computers from Anywhere Using Microsoft Remote Desktop
ShowMyPC has released an online service that lets users log into their Home or Office PC; from anywhere. This is the first hosted service in the world that uses the underlying Microsoft Remote Desktop program. Result, blazing fast performance even over slower connections. (PRWeb Nov 30, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3244934.htm
Quitting Smoking With Electronic Cigarettes: New Study Proves 45% Success Rate
A Recently Completed Medical Study Conducted in South Africa Shows An Impressive 45% Success Rate When Using Electronic Cigarettes As A Smoking Cessation Tool. (PRWeb Nov 30, 2009)
Read the full story at http://www.prweb.com/releases/green-smoke/electroniccigarettereview/prweb3250874.htm
damaka® Launches Video Share and Enhanced Video Calling on Smartphones
damaka’s Video Share provides a truly rich media experience by maximizing the existing cellular network infrastructure (PRWeb Nov 30, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3267534.htm
Millerbernd Laser Receives ISO Certification
Millerbernd Laser recently received ISO 9001:2008 certification from British Standards Institution (BSI), North America's leading management systems registrar. (PRWeb Nov 30, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3270444.htm
Flook Sends Open Letter to Editors of Wikipedia
Flook welcomes departing Wikipedia editors (PRWeb Nov 30, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3273964.htm
2009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women’s Health of North America in Florida
To best serve our patients, their caregivers, and our community, ALL campuses affiliated with the Institute of Women's Health of North America in Florida will offer 2009 H1N1 influenza vaccination. This service is available to all individuals (male and female) 4 years and older. Please visit our website to locate a convenient LOCATION (http://www.iwhna.org/Campuses.aspx) near you or call 1-877-966-3672. (PRWeb Nov 30, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3274204.htm
Bonexcin Captures Market Share as Leading Natural Osteoporosis Supplement
More consumers are turning to the power of PROVEN, all-natural Osteoporosis prevention and treatment supplements – like Bonexcin – because they contain all of the expert-recommended vitamins and minerals required, in one easily-ingested daily supplement. (PRWeb Nov 30, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3271004.htm
Stomach Hormone Can Boost Resistance To Or Slow Down Parkinson’s, Study
US researchers report finding that ghrelin, a hormone produced in the stomach that regulates appetite and how the body deposits fat, may be used to boost resistance to or slow the development of Parkinson’s disease.
EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application (redOrbit)
ROCKLAND, Mass., Nov.
BUSINESS WIRE: The 17^Th Jean-Louis Signoret Neuropsychology Prize of La Fondation Ipsen is Awarded to Doctor Pierre … (vwd.de)
MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.
Merck Serono Receives Refuse to File Letter From FDA on Cladribine Tablets New Drug Application (ITNews)
GENEVA, November 30 /PRNewswire/ — Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that its US affiliate received a refuse to file letter from the US Food and Drug Administration (FDA) on the New Drug Application (NDA) for Cladribine Tablets, Merck Serono’s proprietary investigational oral formulation of cladribine, as a therapy for relapsing forms of multiple …
Stomach Hormone Can Boost Resistance To Or Slow Down Parkinson’s, Study (Medical News Today)
US researchers report finding that ghrelin, a hormone produced in the stomach that regulates appetite and how the body deposits fat, may be used to boost resistance to or slow the development of Parkinson’s disease.
Local Briefs (Asbury Park Press)
Major Wendy J. Galloway received the Athena Award from the Greater Monmouth Chamber of Commerce. Galloway is the first African-American woman to achieve the rank of major with the New Jersey State Police.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research